Somatostatin analogues: Multiple roles in cellular proliferation, neoplasia, and angiogenesis
- 28 March 2004
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 102 (1), 61-85
- https://doi.org/10.1016/j.pharmthera.2004.02.002
Abstract
No abstract availableKeywords
This publication has 162 references indexed in Scilit:
- The biology of VEGF and its receptorsNature Medicine, 2003
- Effect of Somatostatin and Octreotide on Proliferation and Vascular Endothelial Growth Factor Secretion from Murine Endothelial Cell Line (HECa10) CultureBiochemical and Biophysical Research Communications, 2000
- Inhibition of growth of MX-1, MCF-7-MIII and MDA-MB-231 human breast cancer xenografts after administration of a targeted cytotoxic analog of somatostatin, AN-238International Journal of Cancer, 1999
- Antiproliferative and GH-Inhibitory Activity of Chimeric Peptides Consisting of GHRP-6 and SomatostatinBiochemical and Biophysical Research Communications, 1999
- Effect of octreotide, captopril or insulin on renal changes and UAE in long-term experimental diabetesKidney International, 1998
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Synthesis and Secretion of Vascular Permeability Factor/Vascular Endothelial Growth Factor by Human Retinal Pigment Epithelial CellsBiochemical and Biophysical Research Communications, 1993
- Octreotide administration in diabetic rats: Effects on renal hypertrophy and urinary albumin excretionKidney International, 1992
- Effect of a somatostatin analogue (SMS 201–995) on renal function and urinary protein excretion in diabetic ratsJournal of Diabetic Complications, 1991
- SomatostatinNew England Journal of Medicine, 1983